Lenvatinib Plus PD-1 Inhibitors versus Regorafenib in Patients with Advanced Hepatocellular Carcinoma After the Failure of Sorafenib: A Retrospective Study

• मुख्य लेखकों: Xu Y (लेखक), Fu S (लेखक), Liu K (लेखक), Mao Y (लेखक), Wu J (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Dove Medical Press, 2023-10-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Yongkang Xu, Shumin Fu, Kan Liu, Ye Mao, Jianbing Wu Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of ChinaCorrespondence: Jianbing Wu, Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, People�...